Olly Mann and The Week delve behind the headlines and debate what really matters from the past seven days.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Immunotherapy breakthrough
Unionising tech
House revival
-
A newly created gasoline giant in the Americas could change the industry landscapeThe Explainer Sunoco and Parkland are two of the biggest fuel suppliers in the US and Canada, respectively
-
Harvard stares down Trump's tax threat as other Ivies take noteIN THE SPOTLIGHT Higher ed is on high alert as the nation's premier university prepares to take on the fight of its life
-
What to know about Real IDs, America's new identification cardsThe Explainer People without a Real ID cannot board a commercial flight as of May 7, 2025
-
A bacterial toxin could be contributing to the colorectal cancer rise in young peopleUnder the radar Most exposure occurs in childhood
-
Why are more young people getting bowel cancer?The Explainer Alarming rise in bowel-cancer diagnoses in under-50s is puzzling scientists
-
Five medical breakthroughs of 2024The Explainer The year's new discoveries for health conditions that affect millions
-
The mental health crisis affecting vetsUnder The Radar Death of Hampshire vet highlights mental health issues plaguing the industry
-
Covid might be to blame for an uptick in rare cancersThe explainer The virus may be making us more susceptible to certain cancers
-
The alarming rise of cancer in young peopleUnder the radar Cancer rates are rising, and the cause is not clear
-
US bans final type of asbestosSpeed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
-
'Beyond belief': fears of asbestos returnUnder the radar Attention is returning to the dangers of the carcinogenic substance
